|
PureBytes Links
Trading Reference Links
|
Very nice of you to send that Lenny. Every bit of information helps to
complete the puzzle but with MCHM, it is basic. If the phase three trials
go like phase one and two did, there will be every expectation that the
drug will gain approval from the FDA. I would look for $25-$35 on that
news.. If it gets approved for sale, either the company gets taken out in
the $50 area or they market it themselves with dollars from a new partner
and the stock goes to $50-$75. Of course, if the level three phase trial
goes poorly, it will fall back to the $5-$6 range but since I'm in at circa
$3.00, (on most of it anyway, I did add 1K at $7.25 on the dip last week),
my prospects are good to great to over-flow. Who knows... but, I like my
odds. :) Thanks again.
Bob
At 05:03 PM 5/19/2001 -0400, you wrote:
>Bob,
> Here's a MOB Extension on MCHM.
>
>Lenny
>Yahoo! Groups Sponsor
><http://rd.yahoo.com/M=201903.1443829.3021311.1268964/D=egroupmail/S=1700001779:N/A=662183/?http://store.yahoo.com/cgi-bin/clinkform/ydomains+merchant-ad:dmad/M=201903.1443829.3021311.1268964/D=egroupmail/S=1700001779:N/A=662183/R=0/990306246+http://website.yahoo.com>
>Yahoo! Website Services- Click Here!
>
>To unsubscribe from this group, send an email to:
>realtraders-unsubscribe@xxxxxxxxxxxxxxx
>
>
>
>Your use of Yahoo! Groups is subject to the
><http://docs.yahoo.com/info/terms/>Yahoo! Terms of Service.
To unsubscribe from this group, send an email to:
realtraders-unsubscribe@xxxxxxxxxxxxxxx
Your use of Yahoo! Groups is subject to http://docs.yahoo.com/info/terms/
|